• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Atopic Dermatitis Study Results Show Promise

November 13, 2018
Amanda Carrozza

Results from a pilot study show promise for a new atopic dermatitis treatment from KindredBio.

Atopic dermatitis one of the leading reasons for veterinary visits and the second most common allergic skin condition in dogs. Pet parents and veterinarians may be happy to learn that a new therapy is likely on its way.

Kindred Biosciences has announced positive results from its recent pilot study on the effectiveness of KIND-016, the company’s fully caninized, high-affinity monoclonal antibody targeting interleukin-31 (IL-31) for the treatment of atopic dermatitis in dogs.

RELATED:

  • Role of Skin Barrier Dysfunction in Canine Atopic Dermatitis
Advertisement
  • Immune-Stimulating Properties of Probiotics

Thirty-two dogs were enrolled in the randomized, blinded, placebo-controlled laboratory study to assess the effectiveness of KIND-016. The drug was administered at 3 doses. A single dose was administered on day 0 and itching was induced at weeks 1, 2, 3, 4, 6, and 8 with an injection of canine IL-31.

The antibody resulted in statistically significant reductions in pruritus across all dose groups, and results were sustained for 6 to 8 weeks with a clear dose response. The reduction in itching score for dogs that received KIND-06 was as high as 86.1%. Based on a preliminary review of safety data, the drug also appears to be well tolerated.

“Our goal is to develop best-in-class therapies for atopic dermatitis,” said Richard Chin, MD, founder and CEO of KindredBio, “and this is a major step toward that. We believe our fully caninized, high-affinity, IL-31 antibody is well positioned to become an important therapeutic in the space.”

In addition to the study’s results, KindredBio also announced that a patent has been issued for the company’s anti-IL31 antibody.

Related Content:

Dermatology
Comparing treatments for restoring the skin barrier in atopic dogs
Comparing treatments for restoring the skin barrier in atopic dogs
Exploring molecular allergology as the future of allergy testing and immunotherapy
Exploring molecular allergology as the future of allergy testing and immunotherapy
dvm360® is seeking nominations for the 2023 Veterinary Heroes Awards
dvm360® is seeking nominations for the 2023 Veterinary Heroes Awards

Advertisement

Latest News

Comparing treatments for restoring the skin barrier in atopic dogs

Increasing efficiency and productivity in uncertain times

AAVMC awards almost $100,000 in diversity scholarships

News wrap-up: This week’s headlines, plus Maryland Zoo welcomes baby addra gazelle

View More Latest News
Advertisement